Home
About
Overview
Sharing Data
ORCID
Help
History (5)
CpG DNA induces cyclooxygenase-2 expression and prostaglandin production.
Middle School Students' Perceptions of the Lunchroom: Implications for Future Interventions.
Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.
The chemical evolution of oligonucleotide therapies of clinical utility.
Toll-like receptor 9 regulates the lung macrophage phenotype and host immunity in murine pneumonia caused by Legionella pneumophila.
See All 5 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The chemical evolution of oligonucleotide therapies of clinical utility.
Khvorova A, Watts JK. The chemical evolution of oligonucleotide therapies of clinical utility. Nat Biotechnol. 2017 Mar; 35(3):238-248.
View in:
PubMed
subject areas
Animals
Drug Design
Humans
Molecular Targeted Therapy
Oligonucleotides, Antisense
RNA
RNAi Therapeutics
authors with profiles
Jonathan K Watts PhD
Anastasia Khvorova PhD